DEO vs TARS · P/E 16, $55.86B cap vs rev $336.0M
Diageo PLC ADR (DEO) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
Diageo PLC ADR (DEO) is a beverages - wineries & distilleries company listed on US.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
DEO does not have a complete income-statement cache yet.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
DEO currently screens at market cap $55.86B and trailing P/E 15.6. TARS currently screens at market cap $2.66B.
Not investment advice. Open the DEO and TARS stock pages for the full models.
Not investment advice.